Ningbo MedicalSystem Biotechnology Co Ltd (300439) — Cash Flow Quality Index
Ningbo MedicalSystem Biotechnology Co Ltd (300439) has a Cash Flow Quality Index of 13.23x as of September 2025. Operating cash flow of CN¥48.96 Million exceeds net income of CN¥3.70 Million, indicating high earnings quality where cash backs reported profits. Explore 300439 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Ningbo MedicalSystem Biotechnology Co Ltd Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for Ningbo MedicalSystem Biotechnology Co Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Ningbo MedicalSystem Biotechnology Co Lt (300439) cash flow conversion.
Annual Cash Flow Quality Index for Ningbo MedicalSystem Biotechnology Co Ltd (2011–2024)
Year-by-year earnings quality comparison for Ningbo MedicalSystem Biotechnology Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.51x | CN¥397.81 Million | CN¥262.67 Million | ▼ -38.0% |
| 2023 | 2.44x | CN¥633.53 Million | CN¥259.50 Million | ▼ -11.3% |
| 2022 | 2.75x | CN¥564.67 Million | CN¥205.20 Million | ▲ +1.5% |
| 2021 | 2.71x | CN¥515.48 Million | CN¥190.15 Million | ▼ -12.7% |
| 2020 | 3.11x | CN¥912.07 Million | CN¥293.57 Million | ▲ +87.7% |
| 2018 | 1.66x | CN¥418.80 Million | CN¥252.96 Million | ▲ +390.2% |
| 2017 | -0.57x | CN¥-128.40 Million | CN¥225.09 Million | ▼ -4472.8% |
| 2016 | 0.01x | CN¥2.45 Million | CN¥188.10 Million | ▼ -98.8% |
| 2015 | 1.11x | CN¥177.55 Million | CN¥159.46 Million | ▲ +30.7% |
| 2014 | 0.85x | CN¥116.51 Million | CN¥136.79 Million | ▼ -12.1% |
| 2013 | 0.97x | CN¥100.06 Million | CN¥103.26 Million | ▲ +90.0% |
| 2012 | 0.51x | CN¥46.78 Million | CN¥91.73 Million | ▼ -44.3% |
| 2011 | 0.91x | CN¥49.82 Million | CN¥54.45 Million | — |